Jun Zhao

Molar Dose Optimization for Accurate Pharmacokinetic and Biodistribution Evaluation of FAP-Targeted Radiopharmaceuticals in a Mouse Syngeneic Tumor Model.

Disruption of iron homeostasis sensitizes pancreatic cancer to irreversible electroporation.

Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging.

LBA78 KN026 in combination with chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Interim analysis of KC-WISE

Salivary microbial dysbiosis is associated with systemic immune factors in oral squamous cell carcinoma patients

Synthesis and gas sensing properties of palladium nanoparticles-functionalized spindle-like cerium oxide and ferric oxide nanostructure toward highly sensitive xylene detection

Nuclear Molecular Imaging for Evaluating T Cell Exhaustion.

Hybrid graphene and carbon nanotube–reinforced composites: polymer, metal, and ceramic matrices

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer

SEDphone: Spatial encoding of centrifugal microfluidic disc integrated smartphone-controlled platform via RT/LAMP-CRISPR/Cas12a system for influenza virus subtypes detection

First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial

Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance Pancreatic Cancer Therapy

Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance Pancreatic Cancer Therapy.

Histone H3Y99sulf regulates hepatocellular carcinoma responding to hypoxia.

Iodine-induced formation of C–pyridinic-N–Co sites on carbon-encapsulated cobalt nanocrystals as electrocatalyst for rechargeable Zn-air batteries

Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation.

Abstract CT030: Phase I study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors: Updated results of the phase I study

Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂-Mediated Radiotherapy in Triple-Negative Breast Cancer

Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂-Mediated Radiotherapy in Triple-Negative Breast Cancer.

Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment

Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy.

PET imaging of an optimized anti-PD-L1 probe ⁶⁸Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates.

External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer

Phase I dose-escalation study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors.

Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer

Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022).

Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon's Perspective.

1017P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with metastatic squamous (sq) and non-squamous (non-sq) non-small cell lung cancer (NSCLC)

145P Clinical outcomes of atezolizumab in combination with etoposide/platinum for extensive-stage small cell lung cancer in China: A real-world, multi-center, retrospective, controlled study

Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial